Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 9
Merck Challenges Plaintiff's Attempt to Add Sales Representative to Vioxx Claim
Plaintiff Says Pharmacy Can Be Held Liable for Placing Vioxx in Distribution Chain
Sources: Judge Gives Merck Until Feb. 1 to Provide Deposition Dates for CEO
Judge Remands Second Vioxx Case, Says Recovery Against Doctor Possible
Arthritis Drugs - Issue: 8
Abstracts From the Literature:
Study Says Vioxx May Carry Higher RIsk of Myocardial Infarction Than Celebrex
An Interview with David Miceli on Recent Developments
in Vioxx Litigation
An Interview with Dr. Roger S. Blumenthal on Celebrex
and Cardiovascular Risk
FDA Takes on Data Showing CV Risk for Celebrex, Naproxen
